1 Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
2 Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Viral Immunol. 2019 Jun;32(5):208-213. doi: 10.1089/vim.2018.0155. Epub 2019 May 14.
Chronic inflammation is the main risk factor for induction of liver cirrhosis and also hepatocellular carcinoma in chronic hepatitis B (CHB) patients. Although our knowledge is growing regarding molecular mechanisms of immune responses against viruses, the main mechanisms that lead to the progression of chronic inflammation and then CHB are yet to be clarified. IL-18 and IL-1 are the members of the IL-1 family and produced in the cytoplasm of a wide range of immune and nonimmune cells and activated by inflammasome pathways. The cytokines play key roles in the pathologies of CHB. IL-18 and IL-1 productions are altered in CHB patients. It has been hypothesized that the polymorphisms within and genes may be the main reasons for the induction of chronic inflammation in CHB patients. This review article discusses the related investigations regarding the main correlation between the polymorphisms within and genes and CHB pathogenesis.
慢性炎症是诱导慢性乙型肝炎(CHB)患者肝硬化和肝细胞癌的主要危险因素。尽管我们对免疫反应对抗病毒的分子机制的了解在不断增加,但导致慢性炎症进而导致 CHB 的主要机制仍有待阐明。IL-18 和 IL-1 是 IL-1 家族的成员,在广泛的免疫和非免疫细胞的细胞质中产生,并通过炎性小体途径激活。细胞因子在 CHB 的病理生理学中发挥关键作用。IL-18 和 IL-1 的产生在 CHB 患者中发生改变。有人假设 和 基因内的多态性可能是 CHB 患者慢性炎症诱导的主要原因。本文综述了有关 和 基因内多态性与 CHB 发病机制之间主要相关性的相关研究。